Biocon’s arm allots equity shares to Tata Capital Growth Fund II

04 Sep 2020 Evaluate

Biocon’s subsidiary company -- Biocon Biologics India (BBIL) has received approval from board for the allotment of 88 30,456 equity shares of Rs 10 each at an issue price of Rs 254.80 per equity share (including a premium of Rs 244.80 per equity share) to Tata Capital Growth Fund II.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

383.55 -0.50 (-0.13%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×